ATE464912T1 - Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten - Google Patents

Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten

Info

Publication number
ATE464912T1
ATE464912T1 AT04735236T AT04735236T ATE464912T1 AT E464912 T1 ATE464912 T1 AT E464912T1 AT 04735236 T AT04735236 T AT 04735236T AT 04735236 T AT04735236 T AT 04735236T AT E464912 T1 ATE464912 T1 AT E464912T1
Authority
AT
Austria
Prior art keywords
water
substance
high molecular
complexes
medicinal
Prior art date
Application number
AT04735236T
Other languages
English (en)
Inventor
Klaus Sommermeyer
Original Assignee
Supramol Parenteral Colloids Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supramol Parenteral Colloids Gmbh filed Critical Supramol Parenteral Colloids Gmbh
Application granted granted Critical
Publication of ATE464912T1 publication Critical patent/ATE464912T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04735236T 2003-05-30 2004-05-28 Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten ATE464912T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10324710A DE10324710A1 (de) 2003-05-30 2003-05-30 Stärkederivatkomplexe
PCT/EP2004/005801 WO2004105800A2 (de) 2003-05-30 2004-05-28 Komplexierung von arzneistoffen mit hochmolekularen stärke

Publications (1)

Publication Number Publication Date
ATE464912T1 true ATE464912T1 (de) 2010-05-15

Family

ID=33441523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04735236T ATE464912T1 (de) 2003-05-30 2004-05-28 Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten

Country Status (9)

Country Link
US (1) US7932377B2 (de)
EP (1) EP1628684B1 (de)
AT (1) ATE464912T1 (de)
DE (2) DE10324710A1 (de)
DK (1) DK1628684T3 (de)
ES (1) ES2343066T3 (de)
PL (1) PL1628684T3 (de)
PT (1) PT1628684E (de)
WO (1) WO2004105800A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106008746B (zh) * 2016-05-04 2018-11-20 青岛大学 一种纳塔霉素与o,n-羧甲基壳寡糖的接枝共聚物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661349A (en) * 1949-02-18 1953-12-01 Nat Starch Products Inc Polysaccharide derivatives of substituted dicarboxylic acids
US3455838A (en) * 1966-04-22 1969-07-15 Nat Starch Chem Corp Method of encapsulating water-insoluble substances and product thereof
US3892867A (en) * 1974-02-07 1975-07-01 Marten Leonard Schoonman Readily separable instant beverage charge
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
DK0543020T3 (da) * 1991-06-11 1998-08-31 Oxideret sammensætning indeholdende vandopløseligtcarboxypolysaccharid og magnetisk jernoxid
MX9206591A (es) * 1991-11-19 1994-05-31 Nippon Shinyaku Co Ltd Proceso para la produccion de sacaridos.
WO1997033552A1 (en) 1996-03-12 1997-09-18 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
EP0895784B1 (de) 1996-04-15 2005-11-23 Asahi Kasei Kabushiki Kaisha Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden
DE19628705A1 (de) 1996-07-08 1998-01-15 Fresenius Ag Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe
US6132787A (en) * 1997-04-25 2000-10-17 The Procter & Gamble Company Antimicrobial combinations of a sorbate preservative natamycin and a dialkyl dicarbonate useful in treating beverages and other food products and process of making
EP2283872A3 (de) * 1998-04-03 2011-02-23 Mallinckrodt Inc. Nichtkovalente, zur Diagnose und Therapie nützliche Biokonjugate
CA2322344A1 (en) 1999-12-08 2001-06-08 Mallinckrodt Inc. Non-covalent bioconjugates useful for magnetic resonance imaging
AU2001266201A1 (en) 2000-07-01 2002-01-14 M.L. Laboratories Plc Medicaments
DE10112825A1 (de) * 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE10209822A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid

Also Published As

Publication number Publication date
PT1628684E (pt) 2010-06-23
EP1628684B1 (de) 2010-04-21
WO2004105800A2 (de) 2004-12-09
WO2004105800A3 (de) 2005-02-24
ES2343066T3 (es) 2010-07-22
DK1628684T3 (da) 2010-07-26
EP1628684A2 (de) 2006-03-01
US7932377B2 (en) 2011-04-26
US20060183697A1 (en) 2006-08-17
DE502004011073D1 (de) 2010-06-02
PL1628684T3 (pl) 2010-10-29
DE10324710A1 (de) 2004-12-16

Similar Documents

Publication Publication Date Title
CY1121759T1 (el) Παραγωγα peg που περιεχουν δυο αλυσιδες peg
MX2007005724A (es) Articulo para tratamiento cosmetico que comprende un sustrato y una composicion en gel.
ATE259830T1 (de) Polymerkomplexe von glukuronoglukanen
DE60329839D1 (de) Behandlung und verhütung von gewebeschäden, die mit erhöhter produktion von c-reactivem protein verbunden sind
FI20020195A (fi) Metallikomplekseja, jotka sisältävät 2,6-diasyylipyridiiniligandin, ja niiden käyttö eteenin polymerointiin
DE69623449D1 (de) Thyroxine/zyklodextrinkomplexe und ihre pharmazeutische formulierung
DE60017831D1 (de) Dermale zusammensetzungen
ATE455134T1 (de) Polymermaterial mit ketten mit imidazolidonfunktionen
DE69513395D1 (de) Zellulare abgabesystem mit cyclodextrin, für oligonukleotiden
BRPI0910810A2 (pt) conjugados derivados de antraciclina, veículo polimérico, anticorpo, peptídeo ou proteína, veículo t-[cho]m, composições farmacêuticas, métodos de tratamento do câncer ou de distúrbios da proliferação celular, derivado de antraciclina, composto conjugado droga-anticorpo, uso, artigo de manufatura e método de produção de um composto conjugado droga-anticorpo"
WO2004016801A3 (en) Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
ATE364654T1 (de) Polyamideketten von genauer länge und deren konjugate mit proteinen
DE69837443D1 (de) Abbaubare polyethyleneglycolhydrogele mit kontrollierter halbwertzeit und ihre vorprodukte
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
ATE533784T1 (de) Lösliche, einzelkettige proteine des t- zellrezeptors
EP1551834A4 (de) Substituierte quinazolinone verbindungen
ATE217317T1 (de) Triazolinthion-phosphorsäure-derivate
IT1301994B1 (it) Derivati dell'acido ialuronico.
DE60123225D1 (de) Clathratekomplexe auf der basis von hyaluronsäurederivaten und deren verwendung als arzneimittel
TR200200795T2 (tr) 5-HT1B antagonistleri olarak piperazin türevleri
DE60044030D1 (de) Markerkomplexe aus konjugierten polymeren
BRPI0807981A2 (pt) Heparinas de baixo peso molecular, compreendendo pelo menos uma ligação covalente com a biotina ou um derivado da biotina, o respectivo processo de preparo e o respectivo uso
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
DE60326774D1 (de) Konjugate von cyanovirin-varianten und einem polyalkylenoxid
ATE464912T1 (de) Wasserlösliche komplexe von arzneistoffen mit hochmolekularen stärkederivaten